Rachel Rhiannon Davis, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 119 Sader Dr Ste 4, Inwood, WV 25428 Phone: 240-406-9339 |
Lorie Mullan Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 119 Sader Dr Ste 4, Inwood, WV 25428 Phone: 304-278-3010 |
Meagan M Faraone, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 167 1st St, Inwood, WV 25428 Phone: 304-209-4608 |
News Archive
Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.
Common infections in children pose a high risk of ischemic stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Several eye clinics around Sweden are seeing a rise in eye damage related to the racket sport padel. In an article in the Journal of the Swedish Medical Association (Läkartidningen), eye researchers affiliated with the University of Gothenburg state that padel is a potential high-risk sport for eye injuries, and that wearing protective goggles is a good idea.
When used as a treatment, the original Squatty Potty (www.squattypotty.com) toilet stool significantly improves the severity of constipation symptoms within one month of use among 84 percent of the participants of a recently released scientific study.
› Verified 4 days ago